生物医药系列产品
数据
资源
版本对比
免费注册
预约演示
免费注册
Alltracel Pharmaceuticals Plc
Announces a NanopeuticsTM Product and Technology Development License Agreement with
HemCon Medical Technologies, Inc.
to Serve the Military Market
2007-07-19
·
BioSpace
合作
Alltracel Pharmaceuticals Plc
., ("
Alltracel
", or "the Company"), (AIM:AP.L), the
Healthcare Innovation Group
focused on the Woundcare, Oral Care, Dermal Health and Cardiovascular Health markets, today announces its NanopeuticsTM subsidiary has signed a licensing agreement for its technology with
HemCon Medical Technologies, Inc.
, the haemorrhage control market leaders in military markets.
机构
Partnership for Healthcare Value & Innovation
Alltracel Pharmaceuticals Plc
Hemcon Medical Technologies, Inc.
适应症
-
靶点
-
药物
-
标准版
¥
16800
元/账号/年
新药情报库 | 省钱又好用!
立即使用
来和芽仔聊天吧
热门报告
特应性皮炎深度解析:药物开发、专利分析与风险评估
智慧芽生物医药
GPRC5D靶点专利调研报告
智慧芽生物医药
全球潜力靶点及FIC产品研究调研报告
智慧芽生物医药
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
开始免费试用
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。
试用数据服务